1NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis,andTherapy, March 7-29, 2000: highlights of the confer- ence[J].South Med J,2001,94(6):569-73.
5Masi L,Bechenrini L,Gennari L,et al.AIlelic vraiants of human calcitonin receptor distribution and association with bone mass in postmenopausal women.Bioch Biophys Res Commun,1998,245(2):622-626.
6Bandres E,Pombo I,Gonzalez-Huarriz M,et al.Association between bone mineral density and polymorphisms of the VDR,ERalpha,COLIAl and CTR genes in Spanish postmenopausal women.J Endocrinol Invest,2005,28(4):312-321.
7Drews K,Seremak-Mrozikiewicz A,Bartkowiak-Wieczorek J,et al.Genetic polymorphism of the calcitonin receptor gene and bone mineral density in Polish population of postmenopausal women.Ginekof Pof,2005,76(8):612-618.
8Tsai FJ,Chen WC,Chen HY,et al.The ALUI calcitonin receptor gene polymorphism(TT)is associated with low bone mineral density and susceptibility to osteoporosis in postmenopausal women.Gynecol Obstet Invest,2003,:55(2):82-87.
9Kanis JA,Melton JM Ⅲ,Christiansen C,et al.The Diagnosis of osteoporosis.J Bone Miner Res,1994 ;9(8):1137-1141.
10Pocock NA,Eisman JA,Hopper JL,et al.Genetic determinants of hone mass in adults.J Clin Invest,1987;80(9):706-710.
